Little is known about the epidemiology of malaria during pregnancy in areas of unstable (epidemic-prone) transmission (UT) in sub-Saharan Africa. In cross-sectional studies, peripheral malaria parasitemia was identified in 10.4% of women attending antenatal care clinics at 1 stable transmission (ST) site and in 1.8% of women at 3 UT sites; parasitemia was associated with anemia in both ST (relative risk [RR], 2.0; ) P ! .001 and UT (RR, 4.4; ) sites. Placental parasitemia was identified more frequently during deliveries at ST P ! .001 sites (12/185; 6.5%) than at UT sites (21/833; 2.5%; ). Placental parasitemia was associated with low P p .006 birth weight at the ST site (RR, 3.2;
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Malaria infection during pregnancy poses substantial risk to the mother, the fetus, and the neonate. In areas of stable transmission (ST), where adult women have considerable acquired immunity, Plasmodium falciparum infection during pregnancy typically does not cause symptomatic malaria, but it may lead to placental malaria infection and low birth weight (LBW) in newborns [1] [2] [3] . In these areas, primigravidae and, to a lesser extent, secundigravidae are at highest risk for malaria infection and LBW [4] [5] [6] [7] . Primigravidae have higherdensity parasitemia than multigravidae do [5, 8, 9] and are more likely to have placental parasitemia [4, 5, 10] . This placental malarial infection contributes to LBW [2, 4, 5, 11] , which is the single greatest risk factor for neonatal mortality and a major contributor to infant mortality [12] .
In areas of lower or unstable transmission (UT), women do not acquire substantial antimalarial immunity; infection with P. falciparum can cause severe clinical illness and has also been linked to anemia and LBW [13] . Although there are fewer data, there is some evidence to suggest that P. vivax may also be associated with maternal anemia and LBW. One study in western Thailand found that women with P. vivax had a 65% increase in LBW neonates, compared with women without malaria [14] , which is similar to the risk seen with P. falciparum.
The World Health Organization recommends intermittent preventive treatment (IPT) of malaria, which involves the regular and scheduled administration of treatment doses of an antimalarial agent during pregnancy, for women living in areas where transmission is stable and of high intensity [15] . However, the recommendations for women living in areas of UT of P. falciparum in sub-Saharan Africa or for those living in regions where P. vivax is relatively common have not yet been fully developed. In Ethiopia, the Ministry of Health (MOH) stratifies the country into 3 levels with respect to malaria transmission: (1) nonmalarious (25% of the country); (2) highland (also referred to as "unstable malaria"; approximately twothirds of the country); and (3) endemic transmission with seasonal peaks (the remainder of the country) [16, 17] . In addition, ∼40% of malaria cases in the highland areas are caused by P.
vivax [16] . Current MOH policy is for pregnant women to receive chemoprophylaxis with weekly chloroquine and daily proguanil throughout pregnancy [18] , but this policy has never been widely implemented. We undertook 2 cross-sectional studies in Ethiopia to determine the species-specific burden of malaria during pregnancy and to estimate associations with adverse pregnancy outcomes in areas of ST and UT.
SUBJECTS AND METHODS

Study sites.
We selected 3 sites with UT: Bahir Dar (altitude, 1780 m), in the Amhara Region, in north Ethiopia; Jimma (al- titude, 1680 m), in the Oromia Region, in west Ethiopia; and Nazareth (altitude, 1650 m), in the Oromia Region, in the center of the country ( figure 1 ). For comparison, we selected 1 site with ST: Gambella (altitude, 550 m), in the Gambella Region, in the far west of the country, along the Sudanese border (figure 1). We timed the study to occur at the peak of the transmission season and enrolled women from late October 2000 through late January 2001. Study subjects. We enrolled women at antenatal care clinics (ANCs) and delivery units (DUs) at each of the 4 sites. At ANC sites, an attempt was made to enroll an average of 6 women/day. If 16 women attended an ANC on any given day, every other woman was selected until target enrollment was reached. Women 115 years of age who were at 15-34 weeks of gestation, were not allergic to any antimalarial medications, and gave informed consent were enrolled. At DUs, an attempt was made to enroll all eligible women. Women 115 years of age presenting for delivery, for whom the placenta was available for examination, who were not allergic to any antimalarial medications, and who gave informed consent were enrolled.
Clinical procedures. A questionnaire focused on sociodemographic characteristics, history of fever and antimalarial drug use, and the use of antimalarial chemoprophylaxis and insecticide-treated bednets (ITNs) was administered to enrolled women. At the ANCs, an axillary temperature measurement (to the nearest 0.1ЊC) was taken. Capillary blood (ANCs and DU) was obtained through a fingerstick for hemoglobin determination (ANCs), malaria blood film preparation (ANCs and DU), and blotting onto filter paper for polymerase chain reaction (PCR) testing (DU). Placental blood films were prepared by identifying the maternal side of the placenta, wiping away excess blood, cutting into the surface, and placing pooled blood onto a slide. Umbilical cord blood was obtained by wiping away excess blood from a clamped cord, piercing the cord with a lancet, and placing a drop of expressed blood on a slide. Neonates were weighed to the nearest 10 g with an electronic digital scale (Tanita). Gestational age was estimated, using a modified Ballard examination [19] , within 24 h of delivery.
Laboratory procedures. Thick and thin blood films were stained with Giemsa stain and examined for parasites. For thick films, parasites and leukocytes were counted in the same fields until 300 leukocytes or 500 parasites were counted. Parasite densities were estimated using an assumed leukocyte count of 8000 leukocytes/mL of blood. Thin films were used to determine species when thick films were read as positive. All positive blood films and 10% of negative blood films were reread at a reference laboratory in Nazareth. Discordant results were given a third reading at the Centers for Disease Control and Prevention, the result of which was considered to be final. Hemoglobin levels were determined using a HemoCue machine. Confirmation of human Plasmodium species was performed by a modification of the method of Snounou et al. [20] , through the amplification of species-specific ribosomal gene fragments by nested PCR.
Treatment of anemia and malaria. Women at ANCs who were identified as anemic were treated with ferrous sulfate and folic acid. Women with peripheral malaria parasitemia of any density were treated with chloroquine (for P. vivax) and/or sulfadoxine-pyrimethamine (for P. falciparum). Neonates with umbilical cord malaria parasitemia were treated with quinine. All treatments were in accordance with national policies.
Definitions. Blood films (from peripheral, placental, or umbilical cord blood) were considered to be positive if any asexual-stage parasites were identified. Blood films were to be considered negative if no parasites were seen in 100 fields. We defined LBW as !2500 g, prematurity as a gestational age !37 weeks by Ballard examination, anemia as a hemoglobin level !11 g/dL, and moderate-to-severe anemia as a hemoglobin level
Statistical analysis. Data were double entered and validated using Epi Info (version 6; Centers for Disease Control and Prevention). Univariate analyses were performed using the x 2 or Fisher's exact test (for cross-tabulations with an expected value in any cell р5) to compare proportions for categorical variables; Student's t test was used to compare continuous variables. Results were considered to be statistically significant when the 2-sided P value was !.05. Stata 7 software (StataCorp) was used for all statistical analyses.
RESULTS
We enrolled 962 women at ANCs (713 from UT areas and 249 from the ST site) and 1018 women at the DU (833 from UT areas and 185 from the ST site). Overall, 46 eligible women at ANCs (4.6% of all eligible women at ANCs) and 17 eligible women at the DU (1.6% of all eligible women at the DU) refused enrollment. An additional 291 women at ANCs were not selected for enrollment because of excess patient volume. There were no notable differences among enrolled and nonenrolled women (those who refused or were not selected) with regard to median age or primary language.
Characteristics of enrolled women. Characteristics of enrolled women are summarized in table 1. In ANCs, women from the ST site were slightly younger than women from the UT sites (median age, 22 vs. 24 years, respectively) and were less likely to be able to read (57% vs. 78%) or to have attended school (58% vs. 77%). Women from the ST site were also more likely to own their own house (75% vs. 41%). In general, the characteristics of women at the DU were similar to those of women at the ANCs. For women at the DU, the median number of reported previous ANC visits ranged from 5 to 7.
Use of chloroquine chemoprophylaxis was reported by 0.7% of women at ANCs and 1.0% of women at the DU and did not differ between ST and UT zones. Ownership of a bednet was reported by 23.5% of women at ANCs (45.8% in ST and 15.6% in UT zones;
) and 19.3% of women at the DU P ! .001 (50.3% in ST and 12.4% in UT zones;
). The majority P ! .001 of women who owned a bednet reported sleeping under it all or most of the time (79.4% for women at ANCs and 74.0% for women at the DU). The majority of bednets, especially those of women from the ST site, were not treated with insecticide (R.D.N., unpublished observation).
Malaria parasitemia and anemia among women at ANCs. The overall rates of women with malaria parasitemia were 10.4% and 1.8% for ST and UT zones, respectively ( ; table 2). P. vivax was the only organism identified P p .001 in 31% of infections at UT sites, and 15% of infections at UT sites were identified as mixed (P. falciparum and P. vivax); no P. vivax infections were identified at the ST site. Fevers at any time during pregnancy or in the week before enrollment were reported far more frequently in the ST zone (57.0% and 16.5%, respectively) than in UT zones (11.8% and 5.1%, respectively) ( for both). Mean hemoglobin levels were 1.2 g/dL P ! .001 higher in areas of UT ( ). Rates of anemia (hemoglobin P ! .001 level !11 g/dL) and moderate-to-severe anemia (hemoglobin level !8 g/dL) were significantly higher among women in the ST zone than among women in the UT zones. Anemia rates did not differ significantly by gravidity. There were no differences in the rates of parasitemia by gestational age (data not shown).
Women with malaria parasitemia were more likely to have ). P ! .001
Parasitemic women were more likely to have either anemia or moderate-to-severe anemia in both ST and UT zones (table  3) . This relationship was most marked in UT areas, where parasitemic women were 4.4 times as likely (61.5% of parasitemic women vs. 13.9% of aparasitemic women;
) to P ! .001 be anemic and 30.8 times as likely to have moderate-to-severe anemia (30.8% vs. 1.0%; ) as aparasitemic women. P ! .001 Malaria parasitemia and birth outcomes among women at the DU. The overall rates of parasitemia were 7.1% for ST and 2.3% for UT zones ( ; table 4), with a strong as-P p .001 sociation between increasing gravidity and decreasing rates of peripheral malaria parasitemia in the ST zone ( ; x 2 test P p .02 for trend) but not in UT areas. At the ST site, P. vivax was identified in 15.4% of women with peripheral parasitemia, compared with 31.6% at the UT sites. Similar rates were observed for placental parasitemia: 6.5% among women at the ST site and 2.5% among women in UT areas ( ), with P p .006 a similarly significant association between gravidity and rates of placental parasitemia in the stable transmission zone (P p ; x 2 test for trend). At the UT sites, P. vivax was identified .006 in 19.1% of placental infections; no P. vivax was identified in the placentas of women at the ST site.
Mean birth weight was greater among children born to women from UT areas than from the ST area (3168 vs. 2868 g, respectively;
; table 4). The incidences of LBW (15.5% P ! .001 vs. 6.6%;
) and premature delivery (13.9% vs. 5.4%; P ! .001 ) were greater among women in the ST zone than P ! .001 among those in other areas. The highest rate of LBW was observed among primigravidae living in the ST area (20.7%).
Placental parasitemia was associated with an increased risk of LBW among women from the ST zone but not from the UT zone (44.4% vs. 13.8%, respectively; RR, 3.2;
; table P p .01 5), as well as with an increased risk of premature delivery in both ST and UT zones. We also observed a 7.0-fold increased risk of stillbirths (of unknown cause) among women with placental parasitemia (19.1%), compared with aparasitemic women (2.7%) ( ), in UT areas, but not in the ST area. P ! .001 Hospital surveillance for malaria. Surveillance for hospitalized cases of malaria in each of the 4 sites during the study period revealed that 64 (28%) of 228 women hospitalized for malaria were pregnant, and that this percentage was far higher among women from UT areas (43/101; 43%) than those from the ST area (21/127; 17%;
). An additional 10 women P ! .001 (4%) were not currently pregnant but had delivered a child in the previous 30 days. For 27% of pregnancies in women hospitalized for malaria (17/64), a fatal outcome was recorded for the fetus, and for 11%, a fatal outcome was recorded for the woman (7/64). We found no difference in the case-fatality rates for ST and UT areas, nor was there a difference in the casefatality rates for pregnant and nonpregnant women.
DISCUSSION
In 2 cross-sectional studies in Ethiopia, we found that peripheral parasitemia (measured at ANCs and at a DU), as well as placental parasitemia (measured at a DU), was very uncommon (1%-4%) in areas of UT during a nonepidemic year and only moderately common (6%-7%) in an area of stable but low transmission. However, although rates of parasitemia were relatively low, malaria during pregnancy was strongly and signif- icantly associated with adverse pregnancy outcomes, including maternal anemia, LBW, premature delivery, and stillbirths. We also observed that pregnant women appeared to be at a higher risk of hospitalization for malaria than would be expected, especially women from UT areas, and that fatal outcomes for both hospitalized women and their fetuses were not uncommon in the different transmission zones.
These findings confirm previous observations about malaria during pregnancy in areas of unstable, or epidemic-prone, transmission. A cohort study conducted in an area of UT along the Thai-Burmese border demonstrated that women who had malaria at any time during pregnancy were more likely to be anemic than were women without malaria [13] . In contrast to our observations in UT areas of Ethiopia, the Thai study found a significant association between malaria and decreased birth weight. This might be explained by the relatively high incidence of malaria among the women in the refugee setting described in the Thai study (37.2%) and by the observation that most parasitemic women were asymptomatic (90%), which suggests that women have existing antimalarial immunity and, therefore, that a more stable transmission pattern is present than exists in most areas of Ethiopia.
Other studies done in areas of low malaria transmission in Asia have demonstrated associations of malaria during pregnancy with severe illness and LBW [21, 22] ; one of these studies also found an association between febrile illness in the week before delivery and premature birth, as well as increased neonatal and infant mortality [22] . Our findings support the association between febrile illnesses, such as malaria, and premature delivery. Given research that has demonstrated the teratogenic effects of maternal hyperthermia, especially during the first trimester of pregnancy [23, 24] , and our finding of an association between placental parasitemia and stillbirths in UT areas, there is a need for further study of the association of symptomatic malaria with congenital abnormalities and pregnancy loss.
In Africa, there have been few studies of malaria during pregnancy in areas of unstable, or epidemic-prone, transmission. One hospital-based retrospective study conducted in 2 different regions of Uganda found that the risk of hospitalization with malaria and the rate of stillbirths were significantly more common in an area of UT than an area of ST [25] . The same study found that the rates of LBW among primigravidae and secundigravidae were significantly higher among women from the ST site, compared with women from the UT site. Anemia was also more common among women from the ST site. Most malaria-related morbidity measures in this study appeared to vary with variations in rainfall. In Madagascar, a recent study found rates of placental parasitemia in UT areas that are remarkably similar to those found in Ethiopia, with a similarly strong association between placental parasitemia and LBW [26] .
A recent cross-sectional study in a periurban area of low transmission in Uganda found rates of placental parasitemia of 6.7% and reported higher rates of LBW among primigravidae than among secundigravidae or multigravidae [27] . These findings are consistent with rates seen in the ST site in Ethiopia in the present study and suggest that the epidemiology of malaria during pregnancy is related to the stability of transmission, rather than the intensity. It is only when the transmission rate drops to very low intensity and becomes unstable (i.e., epidemic prone) that the majority of pregnant women appear not to maintain antimalarial immunity. In such a setting, the gravid- ity-specific differences observed in areas of ST (whether of high or low intensity) appear to disappear, and the effects of severe malaria (such as hospitalization and stillbirths) become more apparent. This is in contrast to what is seen in ST areas, where, by definition, there is sufficient annual transmission to allow for widespread development of partial antimalarial immunity and consequent predominance of asymptomatic infection and placental sequestration among pregnant women. Unfortunately, insufficient information exists to define these terms entomologically. This study had several limitations. First, this was a nonepidemic year for malaria transmission in Ethiopia. Although we enrolled women at the height of the transmission season for 2000-2001, the rates of malaria parasitemia among women in both the ANCs and the DU were low. Consequently, we were unable to estimate the association between peripheral and placental P. vivax infections and adverse pregnancy outcomes. In addition, we do not know how great the burden of malaria during pregnancy would be during a period of epidemic transmission. Second, because of the need to enroll large numbers of women, this study was conducted in urban or periurban areas where access to ANCs and DUs is greater. If the burden of malaria in these areas is less than that in the surrounding rural regions, then our findings may represent an underestimation of the true burden of malaria during pregnancy in Ethiopia. Third, we did not collect information about treatment or retreatment of bednets with insecticide, although anecdotal evidence suggests that the vast majority of those found in the ST site are locally produced and are not treated.
The challenge for a country such as Ethiopia is to determine what interventions are appropriate, both for areas where transmission is stable but of relatively low intensity and for areas with UT (epidemic-prone transmission). For the latter, the routine and universal use of IPT may be inappropriate, given the very low prevalence of placental parasitemia in nonepidemic years. However, the association with adverse outcomes for pregnant women who become ill with malaria in these regions is unexpectedly strong. There is a clear need to evaluate the magnitude of the burden of malaria during pregnancy during an epidemic and to examine prevention and intervention opportunities.
If such a study demonstrates a significant burden of malaria during pregnancy during an epidemic, then the challenge will be to design interventions that can be included as part of an epidemic-preparedness package. Such interventions might include IPT for all women at regularly scheduled ANC visits after quickening and distribution of ITNs, which could be rapidly implemented at the first sign of an epidemic and then continued until 3-4 months after the epidemic is declared to have ended. In Ethiopia, where ANC coverage is only 27% [28] and use of effective antimalarial prevention strategies by pregnant women is currently very limited, the challenges of delivering interventions will be compounded by the limited ability to reach pregnant women through the formal government health sector; creative community-based delivery systems will be required.
For areas in which transmission is stable but of relatively low intensity, the challenges are different. There is, unfortunately, no specific transmission rate above which general use of IPT makes good public health sense. At a placental parasitemia rate of 7%, a general policy of IPT may deliver antimalarial agents to a substantial proportion of women who are not infected with malaria. However, case management of febrile illnesses may not be a viable option, because febrile illness may not be a useful way of identifying parasitemic women. Given these constraints, there is need for a strategy that is based on prevention but that limits the amount of unnecessary antimalarial agents that are distributed. In such a setting, distribution of ITNs at first ANC visits as part of health education on malaria during pregnancy is an attractive alternative.
